相关实验视频

Updated: Jan 11, 2026

Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells

Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells

Published on: October 10, 2017

中性粒细胞停滞不前不会调解 fosforylation 的增加和与高盐饮食相关的认知障碍

Sung-Ji Ahn¹, Benjamin Goya¹, Christian Bertomo¹

¹Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, 407 East 61st Street, Room 303, New York, NY 10065, USA.

Cardiovascular research

|November 10, 2025

概括

高盐摄入导致毛细血管停滞,减少大脑血流 (CBF) 在小鼠. 然而,这种停滞并不会导致认知能力下降或tau变化,这表明其他机制也参与其中.

科学领域:

神经科学是一个神经科学.
心血管研究研究心血管研究
饮食科学饮食科学

背景情况:

高食盐摄入量是中风和认知障碍的危险因素.
在小鼠中,高盐饮食 (HSD) 降低了脑血流 (CBF),导致陶过酸化,并损害了认知能力.
减少CBF在HSD诱导的病理和认知功能障碍中的作用尚不清楚.

研究的目的:

为了调查毛细血管停滞是否有助于减少CBF,积和认知障碍在HSD下.
测试假设毛细血管停滞是将HSD与脑血管和认知缺陷联系起来的关键机制.

主要方法:

在体内使用双光子成像来评估正常或HSD小鼠的毛细血管停滞.
使用抗Ly6G抗体进行了中性粒细胞枯竭,以评估其对CBF和认知功能的影响.
用巴恩斯迷宫和筑巢行为测试来评估认知障碍.

主要成果:

HSD增加了脑毛细血管中中性粒细胞的停滞,导致CBF减少.
中性粒细胞枯竭减少了毛细血管停滞,并恢复了CBF.
尽管恢复了CBF,但中性粒细胞枯竭并没有挽救HSD诱导的认知障碍或升高的陶酸化.

结论:

毛细血管停滞有助于降低HSD中的CBF,但不会导致陶酸化或认知缺陷.
由于毛细血管停滞而导致的大脑低并不是与HSD相关的病理和认知障碍的主要原因.

关键词:

毛细管的停滞是因为毛细管的停滞.认知障碍认知障碍是一种认知障碍.高盐的饮食高盐的饮食.中性粒细胞中性粒细胞.的酸化是的酸化.

更多相关视频

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein

Published on: January 2, 2015

Author Spotlight: Understanding the Impact of Pathological Proteins on Axonal Transport in Neurodegenerative Diseases

Author Spotlight: Understanding the Impact of Pathological Proteins on Axonal Transport in Neurodegenerative Diseases

Published on: December 22, 2023

相关概念视频

Alzheimer's Disease: Treatment

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...